The price of P3 Health Partners Inc (NASDAQ: PIII) closed at $1.02 in the last session, up 44.33% from day before closing price of $0.71. In other words, the price has increased by $+0.3133 from its previous closing price. On the day, 982718 shares were traded. PIII stock price reached its highest trading level at $1.0300 during the session, while it also had its lowest trading level at $0.7500.
Ratios:
We take a closer look at PIII’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.67 and its Current Ratio is at 0.67. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.65.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on September 01, 2023, initiated with a Buy rating and assigned the stock a target price of $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 13 ’23 when Chicago Pacific Founders UGP I bought 90,000 shares for $2.65 per share. The transaction valued at 238,221 led to the insider holds 50,025,442 shares of the business.
Chicago Pacific Founders UGP I bought 90,000 shares of PIII for $236,520 on Sep 12 ’23. The 10% Owner now owns 49,935,442 shares after completing the transaction at $2.63 per share. On Sep 11 ’23, another insider, Chicago Pacific Founders UGP I, who serves as the 10% Owner of the company, bought 90,000 shares for $2.52 each. As a result, the insider paid 227,142 and bolstered with 50,115,442 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PIII now has a Market Capitalization of 117.55M and an Enterprise Value of 186.79M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.10 while its Price-to-Book (P/B) ratio in mrq is 0.62. Its current Enterprise Value per Revenue stands at 0.16 whereas that against EBITDA is -0.34.
Stock Price History:
Over the past 52 weeks, PIII has reached a high of $5.56, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 1.1246, while the 200-Day Moving Average is calculated to be 1.8322.
Shares Statistics:
According to the various share statistics, PIII traded on average about 445.54K shares per day over the past 3-months and 687.01k shares per day over the past 10 days. A total of 115.24M shares are outstanding, with a floating share count of 47.73M. Insiders hold about 58.59% of the company’s shares, while institutions hold 18.88% stake in the company. Shares short for PIII as of Feb 29, 2024 were 2.29M with a Short Ratio of 5.14, compared to 2.95M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.99% and a Short% of Float of 6.55%.
Earnings Estimates
The company has 4 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.05 and a low estimate of -$0.19, while EPS last year was -$2.26. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.03 and low estimates of -$0.15.
Analysts are recommending an EPS of between -$0.4 and -$1.13 for the fiscal current year, implying an average EPS of -$0.66. EPS for the following year is -$0.26, with 4 analysts recommending between -$0.04 and -$0.54.
Revenue Estimates
According to 5 analysts, the current quarter’s revenue is expected to be $302.97M. It ranges from a high estimate of $309.8M to a low estimate of $300M. As of the current estimate, P3 Health Partners Inc’s year-ago sales were $258.2M, an estimated increase of 17.30% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $345.43M, an increase of 14.40% less than the figure of $17.30% in the same quarter last year. There is a high estimate of $354.8M for the next quarter, whereas the lowest estimate is $329M.
A total of 5 analysts have provided revenue estimates for PIII’s current fiscal year. The highest revenue estimate was $1.23B, while the lowest revenue estimate was $1.22B, resulting in an average revenue estimate of $1.22B. In the same quarter a year ago, actual revenue was $1.05B, up 16.50% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $1.42B in the next fiscal year. The high estimate is $1.47B and the low estimate is $1.36B. The average revenue growth estimate for next year is up 16.50% from the average revenue estimate for this year.
